IP Verse

Amarin Pharmaceuticals Ireland competitive analysis

Loading summary...

Latest patents of Amarin Pharmaceuticals Ireland opposed by its competitors

Explore Amarin Pharmaceuticals Ireland's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3815684
Sep 4, 2024Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy1
EP4056176
Apr 24, 2024Methods Of Reducing The Risk Of Cardiovascular Events In A Subject1
EP2800469
Aug 25, 2021Compositions And Methods For Lowering Levels Of High-Sensitivity (Hs-Crp) In A Subject2
EP3318255
Mar 10, 2021Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin Therapy3
EP3363433
Dec 9, 2020Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy3
EP3278665
Sep 9, 2020Stable Pharmaceutical Composition And Methods Of Using Same1
EP2596786
Nov 27, 2019Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia2
EP3037089
Nov 27, 2019Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia2

Latest publications and patents of Amarin Pharmaceuticals Ireland New

Explore the latest publications and patents granted to Amarin Pharmaceuticals Ireland, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Amarin Pharmaceuticals Ireland

EP3815684
Sep 4, 2024Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyGranted And Under Opposition
EP4056176
Apr 24, 2024Methods Of Reducing The Risk Of Cardiovascular Events In A SubjectGranted And Under Opposition
EP2800469
Aug 25, 2021Compositions And Methods For Lowering Levels Of High-Sensitivity (Hs-Crp) In A SubjectRevoked
EP3318255
Mar 10, 2021Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin TherapyRevoked
EP3363433
Dec 9, 2020Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyGranted And Under Opposition
EP3278665
Sep 9, 2020Stable Pharmaceutical Composition And Methods Of Using SameRevoked
EP3037089
Nov 27, 2019Eicosapentaenoic Acid Ethyl Ester For Treating HypertriglyceridemiaRevoked
EP2596786
Nov 27, 2019Use Of Eicosapentaenoic Acid Ethyl Ester For Treating HypertriglyceridemiaRevoked
EP2443246
Jan 3, 2018Compositions And Methods For Lowering Triglycerides Without Raising Ldl-C Levels In A Subject On Concomitant Statin TherapyNo Opposition Filed Within Time Limit

Latest PTAB cases involving Amarin Pharmaceuticals Ireland

Discover the latest PTAB cases involving Amarin Pharmaceuticals Ireland, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Amarin Pharmaceuticals Ireland

IPR2022-00215Nov 30, 2021HIKMA PHARMACEUTICALS USAAMARIN PHARMACEUTICALS IRELANDTerminated-Settled

Peer Comparison New

IP litigation analysis comparing Amarin Pharmaceuticals Ireland with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AMARIN PHARMACEUTICALS IRELAND - 15 - 1
COOKE27 - - -
ELKINGTON AND FIFE91 - - -
HOFFMANN EITLE148 - - -